Synopsys, Inc. $SNPS Shares Sold by Choreo LLC

Choreo LLC cut its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 21.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,394 shares of the semiconductor company’s stock after selling 950 shares during the period. Choreo LLC’s holdings in Synopsys were worth $1,740,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Symphony Financial Ltd. Co. boosted its holdings in shares of Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after acquiring an additional 39,395 shares during the period. HBW Advisory Services LLC lifted its position in Synopsys by 494.9% in the 2nd quarter. HBW Advisory Services LLC now owns 3,611 shares of the semiconductor company’s stock valued at $1,851,000 after purchasing an additional 3,004 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in Synopsys by 0.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,347,887 shares of the semiconductor company’s stock valued at $691,035,000 after purchasing an additional 4,815 shares during the period. Westbourne Investments Inc. bought a new position in Synopsys in the 2nd quarter worth about $1,505,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Synopsys by 1.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 178,786 shares of the semiconductor company’s stock worth $91,660,000 after purchasing an additional 2,991 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $417.99 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. The stock has a fifty day moving average price of $440.31 and a two-hundred day moving average price of $507.46. The firm has a market cap of $77.64 billion, a P/E ratio of 32.81, a PEG ratio of 5.02 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter last year, the company earned $3.43 EPS. The company’s quarterly revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. cut their price target on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Wells Fargo & Company cut their target price on Synopsys from $550.00 to $445.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Rosenblatt Securities reiterated a “neutral” rating and set a $605.00 price target (down previously from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. The Goldman Sachs Group decreased their price target on Synopsys from $700.00 to $600.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Wall Street Zen cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Hold” and a consensus target price of $556.33.

Insider Buying and Selling at Synopsys

In related news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Robert G. Painter acquired 350 shares of the business’s stock in a transaction dated Thursday, September 11th. The shares were bought at an average price of $425.44 per share, with a total value of $148,904.00. Following the transaction, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. The trade was a 18.03% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. Company insiders own 0.62% of the company’s stock.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.